Illinois CancerCare-Galesburg Cottage Plaza Office — Galesburg, Illinois

Illinois CancerCare-Galesburg Cottage Plaza Office is a clinical research site located in Galesburg, Illinois, United States 61401.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Illinois CancerCare-Galesburg Cottage Plaza Office has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Sponsors: SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Galesburg

Browse all research sites in Illinois · View every site in Galesburg

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare-Galesburg Cottage Plaza Office?

Illinois CancerCare-Galesburg Cottage Plaza Office has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare-Galesburg Cottage Plaza Office conducted?

Illinois CancerCare-Galesburg Cottage Plaza Office has 6 clinical trials on record, with 1 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.

Is Illinois CancerCare-Galesburg Cottage Plaza Office accredited by Crixeo Clinical Trials?

Illinois CancerCare-Galesburg Cottage Plaza Office has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare-Galesburg Cottage Plaza Office?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.